Literature DB >> 9159760

The effects of selective cholinergic basal forebrain lesions and aging upon expectancy in the rat.

J D Stoehr1, S L Mobley, D Roice, R Brooks, L M Baker, R G Wiley, G L Wenk.   

Abstract

The effects of selective cholinergic cell loss within the basal forebrain (BF) were determined using a task that requires shifting of attention between two visual stimuli. Discriminability between two stimuli and response bias were determined in young and old F-344 rats given BF injections of IgG-192 saporin (100 ng). The lesion reduced ChAT activity in the frontal and parietal cortices, hippocampus, and olfactory bulbs. The lesion did not significantly alter Na+/K(+)-ATPase activity in cortex, hippocampus, or olfactory bulbs, or endogenous levels of neuropeptide Y and neurokinin B within the BF. The BF lesions impaired both stimulus discriminability and response bias in young and old rats. The BF lesions had a significantly greater effect upon stimulus discriminability and response bias in aged rats, compared to young rats, only when the stimulus duration was very brief, i.e., when the task was most difficult to solve. At longer stimulus durations, aging and lesions showed no interaction. The results suggest that the selective loss of cholinergic cells in the BF, but not normal aging, impairs the ability to discriminate between independent sensory stimuli. The loss of these cells confers a response bias in simple operant tasks involving motor responses to reward-related visual stimuli.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9159760     DOI: 10.1006/nlme.1997.3768

Source DB:  PubMed          Journal:  Neurobiol Learn Mem        ISSN: 1074-7427            Impact factor:   2.877


  13 in total

1.  Selective behavioral and neurochemical effects of cholinergic lesions produced by intrabasalis infusions of 192 IgG-saporin on attentional performance in a five-choice serial reaction time task.

Authors:  J McGaughy; J W Dalley; C H Morrison; B J Everitt; T W Robbins
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

2.  Age-related loss of calcium buffering and selective neuronal vulnerability in Alzheimer's disease.

Authors:  David Riascos; Dianne de Leon; Alaina Baker-Nigh; Alexander Nicholas; Rustam Yukhananov; Jing Bu; Chuang-Kuo Wu; Changiz Geula
Journal:  Acta Neuropathol       Date:  2011-08-27       Impact factor: 17.088

3.  Effects of a novel CB1 agonist on visual attention in male rats: role of strategy and expectancy in task accuracy.

Authors:  Rikki L A Miller; Ganesh A Thakur; William N Stewart; Joshua P Bow; Shama Bajaj; Alexandros Makriyannis; Peter J McLaughlin
Journal:  Exp Clin Psychopharmacol       Date:  2013-10       Impact factor: 3.157

4.  Neuropathological changes in the nucleus basalis in schizophrenia.

Authors:  M R Williams; R Marsh; C D Macdonald; J Jain; R K B Pearce; S R Hirsch; O Ansorge; S M Gentleman; M Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-12-11       Impact factor: 5.270

5.  Neurokinin-1 receptors in cholinergic neurons of the rat ventral pallidum have a predominantly dendritic distribution that is affected by apomorphine when combined with startle-evoking auditory stimulation.

Authors:  E Mengual; J Chan; D Lane; M San Luciano Palenzuela; Y Hara; A Lessard; V M Pickel
Journal:  Neuroscience       Date:  2007-12-04       Impact factor: 3.590

6.  Loss of calbindin-D28K is associated with the full range of tangle pathology within basal forebrain cholinergic neurons in Alzheimer's disease.

Authors:  Saman S Ahmadian; Aras Rezvanian; Melanie Peterson; Sandra Weintraub; Eileen H Bigio; Marek-Marsel Mesulam; Changiz Geula
Journal:  Neurobiol Aging       Date:  2015-09-06       Impact factor: 4.673

7.  Cholinergic modulation of visual attention and working memory: dissociable effects of basal forebrain 192-IgG-saporin lesions and intraprefrontal infusions of scopolamine.

Authors:  Yogita Chudasama; Jeffrey W Dalley; Falguni Nathwani; Pascale Bouger; Trevor W Robbins; Falgyni Nathwani
Journal:  Learn Mem       Date:  2004 Jan-Feb       Impact factor: 2.460

8.  Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies.

Authors:  Diana W Shineman; Guriqbal S Basi; Jennifer L Bizon; Carol A Colton; Barry D Greenberg; Beth A Hollister; John Lincecum; Gabrielle G Leblanc; Linda Bobbi H Lee; Feng Luo; Dave Morgan; Iva Morse; Lorenzo M Refolo; David R Riddell; Kimberly Scearce-Levie; Patrick Sweeney; Juha Yrjänheikki; Howard M Fillit
Journal:  Alzheimers Res Ther       Date:  2011-09-28       Impact factor: 6.982

9.  The effects of rivastigmine plus selegiline on brain acetylcholinesterase, (Na, K)-, Mg-ATPase activities, antioxidant status, and learning performance of aged rats.

Authors:  Haris Carageorgiou; Antonios C Sideris; Ioanna Messari; Chrissoula I Liakou; Stylianos Tsakiris
Journal:  Neuropsychiatr Dis Treat       Date:  2008-08       Impact factor: 2.570

Review 10.  Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance.

Authors:  Changiz Geula; Sara R Dunlop; Ivan Ayala; Allegra S Kawles; Margaret E Flanagan; Tamar Gefen; Marek-Marsel Mesulam
Journal:  J Neurochem       Date:  2021-08-06       Impact factor: 5.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.